Leung and Stubbs’ diverse professional backgrounds position them to help advance DRIF’s mission to find a cure for diabetes

Left to right: Scarlett Leung; Matthew Stubbs

January 12, 2022 – The Diabetes Research Institute Foundation (DRIF) recently appointed Scarlett Leung, CEO and co-founder of Sugarbreak, and Matthew Stubbs, managing partner at Duncan Stubbs, PLLC, to its national board of directors. Leung and Stubbs join the board with a wide range of leadership, executive and personal experiences in the diabetes community; making them well-poised to guide DRIF’s organizational goals.

“DRIF’s mission of finding the cure for diabetes now is made possible in large part by the unparalleled leadership and expertise of our board members,” said William Fishlinger, Chairman, DRIF National Board of Directors. “We are eager to begin working alongside Scarlett and Matthew and are confident that they will be instrumental in shaping the future of DRIF.”

Leung, a successful entrepreneur, first developed her passion for supporting the diabetes community after witnessing a close friend struggle with type 1 diabetes. Inspired to create an end-to-end solution for blood sugar management, Leung co-founded Sugarbreak, a company that offers all-natural, affordable and accessible solutions to better manage blood sugar. Prior to launching Sugarbreak, Leung successfully led fashion, grocery, and fertility businesses with the common focus of a consumer-oriented vision.

“Being appointed to the Diabetes Research Institute Foundation’s National Board of Directors is an honor and I am eager to work with the talented team at DRIF,” said Scarlett Leung, CEO and co-founder of Sugarbreak. “This cause is personal to me and the mission of DRIF also aligns with my professional passion of providing solutions to those who struggle with diabetes.”

Matthew Stubbs brings more than a decade of legal experience to the board. He is currently the managing partner at national law firm Duncan Stubbs, PLLC, where he provides counsel for individuals harmed by pharmaceutical drugs, medical devices and consumer products. Matthew has lived with type 1 diabetes since he was 12 years old and he’s motivated to support finding a cure for diabetes so that others like him can experience full health.

“I am honored to be appointed to the national board of directors of an organization whose mission is so meaningful to me,” said Matthew Stubbs, managing attorney partner at Duncan Stubbs, PLLC. “This appointment represents the opportunity to make a lasting impact on the lives of those impacted by diabetes.”

Leung and Stubbs appointments take effect on January 1, 2022, and both will serve until June 30, 2023. For more information about DRIF, its mission and its board of directors, visit: https://www.diabetesresearch.org/.

About the Diabetes Research Institute (DRI) and Foundation  

The Diabetes Research Institute (DRI) and Foundation were created for one reason – to cure diabetes – which is and will continue to be the singular focus until that goal is reached. As one of the largest and most comprehensive research centers dedicated to curing diabetes, the DRI is working to restore natural insulin production and normalize blood sugar levels without imposing other risks. Researchers have already shown that transplanted insulin-producing islet cells allow people with type 1 diabetes to live without the need for insulin injections. Some of the DRI’s islet transplant patients have been free from insulin for more than 10 years. Funding provided by the Foundation is the driving force that allows DRI scientists to pursue new and innovative ideas, and to speed these discoveries to patients. The Diabetes Research Institute Foundation is the organization of choice for those who want to Be Part of the Cure. For more information, please visit DiabetesResearch.org or call 800-321-3437. 

About Sugarbreak

Sugarbreak is a natural non-prescription support system that empowers you to reduce your sugar intake and manage healthy blood sugar levels, so you can live your best life. Sugarbreak products are made with natural & scientifically tested ingredients that curb sugar cravings and promote blood sugar management. Sugarbreak aims to reverse the increasingly widespread trends of both obesity and diabetes, which are the result of rising blood sugar, one person at a time. We exist outside the pharmaceutical complex and work alongside the world’s leading scientists and clinicians to provide the research and evidence you deserve. Managing your blood sugar at any age is now Natural, Effective, Safe & Easy. Sugarbreak products are available nationwide at Target, CVS, HyVee grocery stores, and through Emerson Ecologics – the largest clinician retailer in the U.S. Our accessible solutions are positioned to help people in all communities enjoy longer and healthier lives. Achieve and maintain your personal best with Sugarbreak.